用户名: 密码: 验证码:
基于聚氨基酸的钆基磁共振造影剂的制备及其肿瘤成像研究
详细信息    查看官网全文
摘要
MRI技术已成为基础医学和临床诊断中最有力的检测手段之一,特别用于肿瘤的较早期诊断。在临床上大约有50%的MRI检查使用了造影剂,用以增强信号对比度和提高组织图像的分辨率,因此,MRI造影剂的研究也是该领域很重要的方面。目前,临床上使用的造影剂多为小分子造影剂,在成像时间窗口和分辨率上不能满足需要。基于此,我们课题组在大分子造影剂上开展了一些研究:(1)基于赖氨酸采用热聚法制备超支化聚赖氨酸,然后修饰上Gd-DTPA和靶向分子,制备大分子造影剂;(2)以mPEG-NH_2为引发剂,引发天冬氨酸NCA开环聚合,制备分子量可以精确控制的大分子造影剂;(3)在大分子造影剂中引入双硫键,制备了可快速还原裂解的大分子造影剂。通过对不同结构、分子量造影剂的系统研究,探索基于聚氨基酸的钆基磁共振造影剂构建及肿瘤靶向的一般规律和内在机理。
Magnetic resonance imaging(MRI) is a powerful medical imaging modality to display anatomical structures of body, especially useful for the detection and characterization of diseased soft tissues such as solid tumors. According to statistics, nearly 50% of MRI has involved the use of MRI contrast agents(CAs) due to their ability to improve tissue contrast and provide pathological correlation for a wide range of diseases. Our group has worked on the following studies.(1) Hyperbranched polylysine was prepared by thermal polymerization of L-lysine via one-step polycondensation, followed by conjugating with Gd-DTPA and folic acid.(2) A PEGylated block copolymer was prepared by the ring-opening polymerization of β-benzyl-L-aspartate N-carboxy-anhydrideinitiated by the terminal group of mP EG-NH2, of which the molecular weight can by accurately controlled.(3) A macromolecular contrast agent containing biocleavable disulfide bonds was prepared, and its applicability as a MRI contrast agent was demonstrated both in vitro and in vivo.
引文
[1]Dong,J.J.;Liu,M.;Zhang,K.C.;Cao,Y.;Jiang,B.;Zu,G.Y.and Pei,R.J.Bioconjugate Chem.2016,27:151-158.
    [2]Jiang,B.;Liu,M.;Zhang,K.C.;Zu,G.Y.;Dong,J.J.;Cao,Y.;Zhang,L.and Pei,R.J.J.Mater.Chem.B 2016,DOI:10.1039/C6TB00278A.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700